Status:
NOT_YET_RECRUITING
Fibrinogen Concentrates Versus Cryoprecipitate in Liver Transplant Surgery
Lead Sponsor:
Konkuk University Medical Center
Collaborating Sponsors:
Samsung Medical Center
Conditions:
Liver Diseases
Eligibility:
All Genders
20-75 years
Phase:
PHASE4
Brief Summary
We compared the time consumed for goal-directed management of hypofibrinogemia using two strategies during liver transplant (LT) surgery: a conventional cryoprecipitate-based strategy versus a lyophil...
Detailed Description
The primary outcome is an inter-group comparison of treatment time (T-time, the duration from ordering cryoprecipitate or FC to completing its administration). The secondary measures include compariso...
Eligibility Criteria
Inclusion
- Liver disease undergoing Liver transplantation
Exclusion
- \-
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT06144112
Start Date
September 1 2025
End Date
March 31 2026
Last Update
July 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea